4.7 Article

Molecular beacon-enabled purification of living cells by targeting cell type-specific mRNAs

期刊

NATURE PROTOCOLS
卷 9, 期 10, 页码 2411-2424

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nprot.2014.154

关键词

-

资金

  1. National Heart, Lung, and Blood Institute of the US National Institutes of Health (NIH) as a Program of Excellence in Nanotechnology [HHSN268201000043C]
  2. NIH [DP3DK094346]
  3. National Science Foundation Science and Technology Centers (NTC) [CBET-0939511]
  4. Atlanta Clinical and Translational Science Institute (ACTSI) (Clinical and Translational Science Award program) [UL1 RR025008]
  5. Atlanta Clinical and Translational Science Institute (ACTSI) (NIH)
  6. Atlanta Clinical and Translational Science Institute (ACTSI) (National Center for Research Resources)
  7. American Heart Association

向作者/读者索取更多资源

Molecular beacons (MBs) are dual-labeled oligonucleotides that fluoresce only in the presence of complementary mRNA. The use of MBs to target specific mRNAs allows sorting of specific cells from a mixed cell population. In contrast to existing approaches that are limited by available surface markers or selectable metabolic characteristics, the MB-based method enables the isolation of a wide variety of cells. For example, the ability to purify specific cell types derived from pluripotent stem cells (PSCs) is important for basic research and therapeutics. In addition to providing a general protocol for MB design, validation and nucleofection into cells, we describe how to isolate a specific cell population from differentiating PSCs. By using this protocol, we have successfully isolated cardiomyocytes differentiated from mouse or human PSCs (hPSCs) with similar to 97% purity, as confirmed by electrophysiology and immunocytochemistry. After designing MBs, their ordering and validation requires 2 weeks, and the isolation process requires 3 h.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据